Avedro, Inc. Expands Patent Portfolio with Licenses From California Institute of Technology And IROC Innocross

WALTHAM, Mass.--(BUSINESS WIRE)--Avedro Inc., a Boston-based ophthalmic pharmaceutical and medical device company announced today that it has significantly expanded its patent portfolio. Avedro obtained an exclusive license to a patent held by the California Institute of Technology in the field of corneal cross-linking using ultraviolet light. This method patent (U.S. Patent No. 8,414,911) covers two key cross-linking applications: accelerated cross-linking and corneal cross-linking used during refractive surgery.

Help employers find you! Check out all the jobs and post your resume.